Authors:
TEBBE U
GUNZLER WA
HOPKINS GR
GRYMBOWSKI T
BARTH H
Citation: U. Tebbe et al., THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL-INFARCTION WITH SARUPLASE, ASINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (SCU-PA) FROM RECOMBINANT BACTERIA, Fibrinolysis & proteolysis, 11, 1997, pp. 45-54
Authors:
VANGRIENSVEN JMT
KOSTER RW
HOPKINS GR
BEIER H
GUNZLER WA
KROON R
SCHOEMAKER RC
COHEN AF
Citation: Jmt. Vangriensven et al., EFFECT OF CHANGES IN LIVER BLOOD-FLOW ON THE PHARMACOKINETICS OF SARUPLASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, Thrombosis and haemostasis, 78(3), 1997, pp. 1015-1020
Authors:
VANGRIENSVEN JMT
BURGGRAAF KJ
GERLOFF J
GUNZLER WA
BEIER H
KROON R
HUISMAN LGM
SCHOEMAKER RC
KLUFT K
COHEN AF
Citation: Jmt. Vangriensven et al., EFFECTS OF CHANGING LIVER BLOOD-FLOW BY EXERCISE AND FOOD ON KINETICSAND DYNAMICS OF SARUPLASE, Clinical pharmacology and therapeutics, 57(4), 1995, pp. 381-389
Authors:
KOSTER RW
COHEN AF
HOPKINS GR
BEIER H
GUNZLER WA
VANDERWOUW PA
Citation: Rw. Koster et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF SARUPLASE, AN UNGLYCOSYLATEDSINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, Thrombosis and haemostasis, 72(5), 1994, pp. 740-744
Authors:
DEBOER A
KLUFT C
GERLOFF J
DOOIJEWAARD G
GUNZLER WA
BEIER H
VANDERMEER FJM
COHEN AF
Citation: A. Deboer et al., PHARMACOKINETICS OF SARUPLASE, A RECOMBINANT UNGLYCOSYLATED HUMAN SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS EFFECTS ON FIBRINOLYTIC AND HEMOSTATIC PARAMETERS IN HEALTHY MALE-SUBJECTS, Thrombosis and haemostasis, 70(2), 1993, pp. 320-325
Authors:
HOFFMANN JJML
MICHELS HR
WINDELER J
GUNZLER WA
Citation: Jjml. Hoffmann et al., PLASMA MARKERS OF THROMBIN ACTIVITY DURING CORONARY THROMBOLYTIC THERAPY WITH SARUPLASE OR UROKINASE - NO PREDICTION OF REINFARCTION, Fibrinolysis, 7(5), 1993, pp. 330-334